|
|
|||||||||||
Grampian Primary Care Trust, Royal Cornhill Hospital, Aberdeen AB25 2ZH, email: olga.runcie{at}gpct.grampian.scot.nhs.uk
Tayside Health Board, Centre for Child Health, Dundee
Grampian Primary Care Trust, Royal Cornhill Hospital, Aberdeen
R.H. has received fees for speaking and attending meetings from Pfizer, Lundbeck, Lilly and AstraZeneca. M.B. has taken part in research projects funded by Pfizer.
AIMS AND METHOD
Following a survey in 2001, a protocol for monitoring weight and blood glucose of psychiatric in-patients receiving antipsychotic drugs was developed. The effect of this protocol was investigated by comparing 61 admissions in 2004 with the 2001 in-patients.
RESULTS
No significant improvement in recording of admission weight or blood glucose was observed. Ongoing monitoring of weight after admission was significantly more common. For only 29% of patients studied in 2004 was there complete adherence to the protocol.
CLINICAL IMPLICATIONS
In spite of the availability of a protocol and education, the results suggest that monitoring of weight and blood glucose is still haphazard for psychiatric in-patients. The implications for out-patient monitoring are discussed.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| British Journal of Psychiatry | Advances in Psychiatric Treatment | All RCPsych Journals |